NewGenIvf Group Inventory 2023-2024 | NIVF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NewGenIvf Group inventory from 2023 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NewGenIvf Group inventory from 2023 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$147.1B
CVS Health (CVS)	$76.8B
Elevance Health (ELV)	$65.1B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$25.7B
Labcorp Holdings (LH)	$22.2B
Natera (NTRA)	$19B
BioMerieux (BMXMF)	$17.7B
EUROFINS SCIENT (ERFSF)	$15.9B
ICON (ICLR)	$15.1B
CochLear (CHEOY)	$13.4B
Solventum (SOLV)	$12.9B
Medpace Holdings (MEDP)	$12.6B
Revvity (RVTY)	$12.2B
Viatris (VTRS)	$11B
Avantor (AVTR)	$9.7B
Sonic Healthcare (SKHHY)	$9.1B
Charles River Laboratories (CRL)	$8.7B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$7.5B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5.1B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.5B
Surgery Partners (SGRY)	$2.7B
Organon (OGN)	$2.7B
Concentras Parent (CON)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B